-+ 0.00%
-+ 0.00%
-+ 0.00%

ABBISKO THERAPEUTICS ANNOUNCES POSITIVE PRELIMINARY PHASE 2 RESULTS WITH LAVENGRATINIB (ABSK061) FOR THE TREATMENT OF ACHONDROPLASIA

路透·09/21/2026 01:00:03

登录查看新闻详情